Lynch syndrome diagnostics:: decision-making process for germ-line testing

• Autores: E. Lastra Aras, María García González, Beatriz Llorente Ayala, Coralina Bernuy Guevara, M. Jesús Barrio, Lucía Pérez Cabornero, Mercedes Durán Domínguez, Carlos García Girón
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 14, Nº. 4, 2012, págs. 254-262
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Cancer risks and medical management of Lynch syndrome (LS) differ from other hereditary or familial clustering of colorectal cancer. Differential diagnosis has improved as a result of the growing clinical and molecular knowledge about LS. Appropriate application of these advances in several scenarios constitutes a decision-making process to further decide germ-line testing with accuracy and efficiency. However, an only molecular-screening algorithm, with a limited number of steps and choices, may be difficult to devise. How, when, where and at what expense to use the different diagnostic tools remain dynamic and changeable under different circumstances. From a clinical point of view, it is advisable to discuss conflicting aspects to guide LS diagnosis.